Quick Answer
GALECTIN THERAPEUTICS INC reported Total Assets of $19.53 million for fiscal year 2025.
GALECTIN THERAPEUTICS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $19.53M | +11.6% |
| 2024 | $17.50M | -38.0% |
| 2023 | $28.20M | +32.5% |
| 2022 | $21.29M | -49.1% |
| 2021 | $41.83M | +41.3% |
| 2020 | $29.60M | -38.9% |
| 2019 | $48.47M | +438.2% |
| 2018 | $9.01M | +116.4% |
| 2017 | $4.16M | -73.7% |
| 2016 | $15.79M | -40.2% |
| 2015 | $26.41M | -11.0% |
| 2014 | $29.68M | +177.0% |
| 2013 | $10.71M | +12.0% |
| 2012 | $9.56M | +44.6% |
| 2011 | $6.61M | +5.0% |
| 2010 | $6.30M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.87M | -55.6% | -17.5% |
| June 30, 2025 | $15.60M | -43.6% | +63.7% |
| March 31, 2025 | $9.53M | -63.2% | -45.5% |
| December 31, 2024 | $17.50M | -38.0% | -39.6% |
| September 30, 2024 | $28.97M | +30.7% | +4.8% |
| June 30, 2024 | $27.66M | +37.7% | +6.8% |
| March 31, 2024 | $25.89M | +28.0% | -8.2% |
| December 31, 2023 | $28.20M | +32.5% | +27.2% |
- GALECTIN THERAPEUTICS INC showed an increase of +11.6% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, GALECTIN THERAPEUTICS INC’s total assets has grown by 210.0% (from $6.30 million to $19.53 million).
- The most recent figure is from GALECTIN THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: